VACCINE FOR PREVENTION OF LYME BORRELIOSIS
The invention provides a vaccine for prevention of Lyme borreliosis containing at least two types of chimeric poly epitope recombinant antigens, comprising immunodominant regions of OspA and OspC antigens, and at least one adjuvant and/or ferritin II. L'invention concerne un vaccin pour la prév...
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
12.11.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides a vaccine for prevention of Lyme borreliosis containing at least two types of chimeric poly epitope recombinant antigens, comprising immunodominant regions of OspA and OspC antigens, and at least one adjuvant and/or ferritin II.
L'invention concerne un vaccin pour la prévention de la borréliose de Lyme contenant au moins deux types d'antigènes recombinants polyépitopes chimères, comprenant des régions immunodominantes d'antigènes OspA et OspC, et au moins un adjuvant et/ou de la ferritine II. |
---|---|
Bibliography: | Application Number: WO2015CZ00042 |